A Case of Recurrent Hepatocellular Carcinoma Acquiring Complete Remission of Target Lesion With Treatment With Traditional Chinese Medicine

Overview

Journal Integr Cancer Ther

Publisher Sage Publications

Specialties Oncology
Pharmacology

Date 2016 Jul 23

PMID 27444311

Citations 7

Authors

Chen Jianxin

Xu Qingxia

Wang Junhui

Zheng Qinhong

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies worldwide. Although surgery is known as the most promising radical treatment, a high recurrent or metastatic rate after surgery has limited its clinical efficacy. Sorafenib, a target agent, has seemed to be the only option for metastatic HCC patients to date, but none of clinical trials showed it could prolong the overall survival (OS) of advanced HCC to 1 year. How to prolong the OS and improve cure rate of HCC patients is still beset with difficulties. This report presents a rare case of recurrent HCC patient with complete regression of target lesion with 2 years of Chinese herbal treatment. A 64-year-old Chinese man with hepatitis B virus-associated chronic hepatitis presented HCC has been clinically diagnosed tumor relapse and omentum metastasis with computed tomography and α-fetoprotein blood test 4 months after surgery. It was decided the patient would receive traditional Chinese medicine treatment because of poor prognosis. After approximately 2 years of treatment, recurrent hepatic tumor and omentum metastasis have been found in complete regression. The patient remains alive over 31 months after relapse.

Citing Articles

A Case of Spontaneous Remission of Non-Hodgkin's Lymphoma in the Lung.

Li S, Yu F, Yanfen S Clin Case Rep. 2025; 13(3):e70265.

PMID: 40018428 PMC: 11865011. DOI: 10.1002/ccr3.70265.

A Curious Case of Vanishing Hepatocellular Carcinoma (HCC).

Kwei-Nsoro R, Attar B, Ojemolon P, Annor E, Go B Cureus. 2023; 15(10):e46576.

PMID: 37933367 PMC: 10625688. DOI: 10.7759/cureus.46576.

YinQiSanHuang Jiedu decoction for the treatment of hepatitis B-related compensated liver cirrhosis: study protocol for a multi-center randomized controlled trial.

Wu Q, Lv W, Li J, Zhang T, Zhou W, Zhang Q Trials. 2021; 22(1):701.

PMID: 34649610 PMC: 8515328. DOI: 10.1186/s13063-021-05650-6.

Recent Advances in Anti-Metastatic Approaches of Herbal Medicines in 5 Major Cancers: From Traditional Medicine to Modern Drug Discovery.

Park J, Jeong D, Song M, Kim B Antioxidants (Basel). 2021; 10(4).

PMID: 33801741 PMC: 8065873. DOI: 10.3390/antiox10040527.

Bie Jia Jian Pill Combined with Bone Mesenchymal Stem Cells Regulates microRNA-140 to Suppress Hepatocellular Carcinoma Stem Cells.

Jingjing H, Hongna H, Wenfu Z, Jianlin L, Guochu H, Yuanjia L Int J Stem Cells. 2021; 14(3):275-285.

PMID: 33632990 PMC: 8429943. DOI: 10.15283/ijsc20157.

References

Zhang H, Wang Y, Zhang J, Zhang Q . Artemisinin inhibits gastric cancer cell proliferation through upregulation of p53. Tumour Biol. 2013; 35(2):1403-9. DOI: 10.1007/s13277-013-1193-1. View

Wen J, Wei X, Sheng X, Zhou D, Peng H, Lu Y . Effect of Ursolic Acid on Breast Cancer Resistance Protein-mediated Transport of Rosuvastatin In Vivo and Vitro. Chin Med Sci J. 2016; 30(4):218-25. DOI: 10.1016/s1001-9294(16)30004-9. View

Li X, Lin Z, Zhang B, Guo L, Liu S, Li H . β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1. Sci Rep. 2016; 6:21010. PMC: 4751482. DOI: 10.1038/srep21010. View

Zaman M, Chauhan N, Yallapu M, Gara R, Maher D, Kumari S . Curcumin Nanoformulation for Cervical Cancer Treatment. Sci Rep. 2016; 6:20051. PMC: 4738284. DOI: 10.1038/srep20051. View

Hu Z, Wu H, Li Y, Hou Q, Wang Y, Li S . β-Elemene inhibits the proliferation of esophageal squamous cell carcinoma by regulating long noncoding RNA-mediated inhibition of hTERT expression. Anticancer Drugs. 2015; 26(5):531-9. DOI: 10.1097/CAD.0000000000000216. View

Meng Y, Lin Z, Ge N, Zhang D, Huang J, Kong F . Ursolic Acid Induces Apoptosis of Prostate Cancer Cells via the PI3K/Akt/mTOR Pathway. Am J Chin Med. 2015; 43(7):1471-86. DOI: 10.1142/S0192415X15500834. View

Wu J, Zhao S, Tang Q, Zheng F, Chen Y, Yang L . Activation of SAPK/JNK mediated the inhibition and reciprocal interaction of DNA methyltransferase 1 and EZH2 by ursolic acid in human lung cancer cells. J Exp Clin Cancer Res. 2015; 34:99. PMC: 4567809. DOI: 10.1186/s13046-015-0215-9. View

Rajitha B, Belalcazar A, Nagaraju G, Shaib W, Snyder J, Shoji M . Inhibition of NF-κB translocation by curcumin analogs induces G0/G1 arrest and downregulates thymidylate synthase in colorectal cancer. Cancer Lett. 2016; 373(2):227-33. DOI: 10.1016/j.canlet.2016.01.052. View

Yang Y, Jiang M, Hu J, Lv X, Yu L, Qian X . Enhancement of Radiation Effects by Ursolic Acid in BGC-823 Human Adenocarcinoma Gastric Cancer Cell Line. PLoS One. 2015; 10(7):e0133169. PMC: 4503735. DOI: 10.1371/journal.pone.0133169. View

10.

Seo J, Kim B, Dhanasekaran D, Tsang B, Song Y . Curcumin induces apoptosis by inhibiting sarco/endoplasmic reticulum Ca2+ ATPase activity in ovarian cancer cells. Cancer Lett. 2015; 371(1):30-7. DOI: 10.1016/j.canlet.2015.11.021. View

11.

Chen J, Chang N, Chung J, Chen K . Saikosaponin-A induces apoptotic mechanism in human breast MDA-MB-231 and MCF-7 cancer cells. Am J Chin Med. 2003; 31(3):363-77. DOI: 10.1142/S0192415X03001065. View

12.

Ai Y, Zhu B, Ren C, Kang F, Li J, Huang Z . Discovery of New Monocarbonyl Ligustrazine-Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer. J Med Chem. 2016; 59(5):1747-60. DOI: 10.1021/acs.jmedchem.5b01203. View

13.

Kim J, K Jayaprakasha G, Patil B . Limonoids and their anti-proliferative and anti-aromatase properties in human breast cancer cells. Food Funct. 2012; 4(2):258-65. DOI: 10.1039/c2fo30209h. View

14.

Zeng X, Li X, Xue X, Shi Z, Feng P, Wang P . Activation of apoptosis in hepatocellular carcinoma by the Chinese traditional medicine Hu Qisan. Exp Ther Med. 2013; 5(3):695-700. PMC: 3570238. DOI: 10.3892/etm.2012.862. View

15.

Yeh Y, Chen H, Yang S, Lin Y, Chiu J, Lin Y . Hedyotis diffusa Combined with Scutellaria barbata Are the Core Treatment of Chinese Herbal Medicine Used for Breast Cancer Patients: A Population-Based Study. Evid Based Complement Alternat Med. 2014; 2014:202378. PMC: 3966415. DOI: 10.1155/2014/202378. View

16.

Ilamathi M, Santhosh S, Sivaramakrishnan V . Artesunate as an Anti-Cancer Agent Targets Stat-3 and Favorably Suppresses Hepatocellular Carcinoma. Curr Top Med Chem. 2016; 16(22):2453-63. DOI: 10.2174/1568026616666160212122820. View

17.

Liu L, Zuo L, Zuo J, Wang J . Artesunate induces apoptosis and inhibits growth of Eca109 and Ec9706 human esophageal cancer cell lines in vitro and in vivo. Mol Med Rep. 2015; 12(1):1465-72. DOI: 10.3892/mmr.2015.3517. View

18.

Thomas M, OBeirne J, Furuse J, Chan A, Abou-Alfa G, Johnson P . Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy. Ann Surg Oncol. 2008; 15(4):1008-14. DOI: 10.1245/s10434-007-9705-0. View

19.

Ting C, Li W, Chen C, Tsai T . Preventive and therapeutic role of traditional Chinese herbal medicine in hepatocellular carcinoma. J Chin Med Assoc. 2014; 78(3):139-44. DOI: 10.1016/j.jcma.2014.09.003. View

20.

Llovet J, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc J . Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008; 359(4):378-90. DOI: 10.1056/NEJMoa0708857. View